Peter Schraml

17.2k citations
167 papers · 14.4k · 2 hit papers · h-index 58

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers

Papers in

Peter Schraml

166 papers receiving 14k citations

Peter Schraml's Hit Papers

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. 1999 · 503 citations
5030+9+18Years since publication1k2k3k

Peers

Peter Schraml
Comparison fields: 5 of 128
  • Cancer Research 2.7k
  • Oncology 2.6k
  • Pulmonary and Respiratory Medicine 3.6k
  • Molecular Biology 3.5k
  • Genetics 438
Replace Kerstin Junker with:
Kerstin Junker Germany
Yoon‐La Choi South Korea
Yichao Sun United States
Michael Ryan United States
Daniel Baumhoer Switzerland
Peter Remsen Dottino United States
Dejan Juric United States
Henri Timmers United States
Katherine Stemke‐Hale United States
Roberto Tirabosco United Kingdom
Peter Schraml relative to Kerstin Junker Germany Kerstin Junker's profile →
Citations per field
00.5×1.5×2.1×
Kerstin Junker · 1×
Citations per year

Countries citing papers authored by Peter Schraml

Since Specialization
Citations

This map shows the geographic impact of Peter Schraml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schraml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schraml more than expected).

Fields of papers citing papers by Peter Schraml

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Schraml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schraml. The network helps show where Peter Schraml may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Schraml, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Schraml Line = papers co-authored together Peter Schraml links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Hit paper breakdown →
19983491
2
Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
Hit paper breakdown →
1999503
3
Tissue microarrays for gene amplification surveys in many different tumor types.
1999388
4 2017322
5 1999320
6 2004301
7 1999299
8
Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.
2000281
9 2001272
10 2001251
11 2000216
12 2004205
13 1998201
14 2012192
15 2001187
16 2004187
17
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
2001165
18 2021163
19 2016161
20 2017154

About Peter Schraml

Peter Schraml is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Surgery, having authored 167 papers that have together received 14.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (63 papers), Cancer Genomics and Diagnostics (15 papers), Bladder and Urothelial Cancer Treatments (14 papers), Cancer, Hypoxia, and Metabolism (13 papers), Breast Cancer Treatment Studies (12 papers), Prostate Cancer Treatment and Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Chromatin Remodeling and Cancer (5 papers). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (2.6k citations), Pulmonary and Respiratory Medicine (3.6k citations), Molecular Biology (3.5k citations) and Genetics (438 citations). Peter Schraml has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Holger Moch, Guido Sauter, Michael Jörg Mihatsch, Juha Kononen, Lukas Bubendorf, Joachim K. H. Torhorst, Stephen B. Leighton, Maarit Tuulikki Barlund, Olli Kallioniemi and Ronald Simon. Their work appears in journals such as American Journal Of Pathology, Oncogene, The Journal of Pathology, Modern Pathology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact